Icosavax: AstraZeneca in 875m swoop on US vaccine firm

AstraZeneca has agreed to buy its first vaccine company for £875m, writes Leah Montebello. The deal to takeover Icosavax will expand the infectious disease business the pharma giant set up during the pandemic. Britain's biggest drugmaker said it will take over the Seattle-based group, which is developing an injection that targets both respiratory syncytial virus [...]